Jack W. Callicutt
2019
In 2019, Jack W. Callicutt earned a total compensation of $778.1K as Chief Financial Officer at Galectin Therapeutics, a 39% decrease compared to previous year.
Compensation breakdown
| Bonus | $233,450 |
|---|---|
| Option Awards | $191,568 |
| Salary | $285,000 |
| Other | $68,105 |
| Total | $778,123 |
Callicutt received $285K in salary, accounting for 37% of the total pay in 2019.
Callicutt also received $233.5K in bonus, $191.6K in option awards and $68.1K in other compensation.
Rankings
In 2019, Jack W. Callicutt's compensation ranked 10,333rd out of 13,971 executives tracked by ExecPay. In other words, Callicutt earned more than 26.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,333 out of 13,971 | 26th |
Division Manufacturing | 4,179 out of 5,695 | 27th |
Major group Chemicals And Allied Products | 1,604 out of 2,194 | 27th |
Industry group Drugs | 1,373 out of 1,880 | 27th |
Industry Pharmaceutical Preparations | 1,022 out of 1,392 | 27th |
Source: SEC filing on October 19, 2020.
Callicutt's colleagues
We found one more compensation record of an executive who worked with Jack W. Callicutt at Galectin Therapeutics in 2019.
2019
Harold Shlevin
Galectin Therapeutics